Fluditek syrup 5% fl. 125ml for adults

Release form, composition and packaging

The syrup is in the form of a clear green liquid with a caramel smell.

10 ml

carbocisteine ​​50 mg

glycerol - 5 g, methyl parahydroxybenzoate - 150 mg, sucrose - 35 g, sunset yellow dye (E110) - 1.6 mg, patented blue dye V (E131) - 1 mg, sodium hydroxide - up to pH6.2, caramel flavor - 200 mg , purified water - up to 100 ml.

125 ml - glass bottles (1) - cardboard packs.

pharmachologic effect

Mucolytic drug.

Mucolytic and expectorant action is due to the activation of sialic transferase - an enzyme of the goblet cells of the bronchial mucosa.

Normalizes the quantitative ratio of acidic and neutral sialomucins of bronchial secretion, restores the viscosity and elasticity of mucus, facilitates its discharge.

Promotes regeneration of the mucous membrane, normalizes its structure, activates the activity of the ciliated epithelium, improves mucociliary clearance.

Restores the secretion of immunologically active IgA (specific protection) and the amount of sulfhydryl groups of mucus components (non-specific protection).

Pharmacokinetics

Suction

After oral administration, Cmax in the blood serum and in the mucous membrane of the respiratory tract is achieved 2-3 hours after ingestion and remains in the mucous membrane for 8 hours.

Withdrawal

It is excreted mainly in the urine, partly unchanged, partly in the form of metabolites.

Indications for use

- acute and chronic bronchopulmonary diseases, accompanied by the formation of viscous, difficult to separate sputum (tracheitis, bronchitis, tracheobronchitis, bronchial asthma, bronchiectasis)

- acute and chronic inflammatory diseases of the nasal cavity, nasopharynx, paranasal sinuses and middle ear, accompanied by the formation of viscous, difficult to separate mucus (rhinitis, adenoiditis, sinusitis, otitis media)

- preparation for bronchoscopy and / or bronchography.

Contraindications for use

- peptic ulcer of the stomach and duodenum in the acute phase

- chronic glomerulonephritis (in the acute phase), cystitis

- children under 2 years of age (for syrup 20 mg / ml for children) and up to 15 years (for syrup 50 mg / ml)

- I trimester of pregnancy (for syrup 50 mg / ml)

- hypersensitivity to carbocisteine ​​or other components of the drug.

Care should be taken to prescribe the drug for chronic glomerulonephritis (history), gastric ulcer and duodenal ulcer (history).

Dosage regimen

Syrup 20 mg / ml for children

1 teaspoon (5 ml) contains 100 mg carbocysteine.

Children aged 2 to 5 years are prescribed 1 teaspoon (5 ml) 2 times / day, the daily dose should not exceed 200 mg

children over 5 years old are prescribed 1 teaspoon (5 ml) 3 times / day, the daily dose should not exceed 300 mg.

Treatment should not continue for more than 8-10 days without consulting a doctor.

Syrup 50 mg / ml

1 tablespoon (15 ml) contains 750 mg of carbocysteine.

Children over 15 years old and adults are prescribed 1 tablespoon (15 ml) 3 times / day, preferably 1 hour before meals or 2 hours after meals.

Treatment should not continue for more than 8-10 days without consulting a doctor.

Overdose

Symptoms: gastralgia, nausea, diarrhea.

Treatment: symptomatic therapy is performed.

Side effect

From the digestive system: nausea, vomiting, diarrhea, epigastric pain, flatulence, gastrointestinal bleeding.

From the side of the central nervous system: dizziness, weakness, malaise.

Allergic reactions: in isolated cases - itching, urticaria, exanthema, angioedema.

Drug interactions

With the simultaneous use of Fluditec increases the effectiveness of glucocorticosteroid (mutually) and antibacterial therapy for inflammatory diseases of the upper and lower respiratory tract.

With the simultaneous use of Fluditec enhances the bronchodilator effect of theophylline.

Name ENG

FLUDITEC

Clinical and pharmacological group

Mucolytic drug

ATX code

Carbocisteine

Dosage

50mg / ml x 125ml

Indications

Diseases of the respiratory system, accompanied by the release of a large amount of viscous mucus: acute and chronic bronchitis, tracheobronchitis, bronchitis with broncho-obstructive syndrome, bronchial asthma, whooping cough, bronchiectasis

inflammatory diseases of the middle ear and sinuses

preparation of the patient for bronchoscopy and / or bronchography.

Storage conditions and periods

At a temperature not higher than 25 degrees.

Expiration date: 2 years

INN / Active ingredient

carbocisteine

Contraindications

Peptic ulcer and duodenal ulcer in the acute phase, chronic glomerulonephritis in the acute phase, I trimester of pregnancy, hypersensitivity to carbocysteine.

Specifications

Category

Thinning phlegm

,

Expectorants

Scope of the drug

Respiratory system

Release form

Syrup

Manufacturer country

France

Package quantity, pcs

one

Vacation conditions

Without recipe

Volume, ml.

125 ml

Brand name

InnoTech

Components

measuring glass

The amount of the dosage form in the primary package

125 ml

Primary packaging type

Bottle

Type of consumer packaging

Pack of cardboard

Pharmaco-therapeutic group

Expectorant mucolytic agent

Anatomical and therapeutic characteristics

R05CB03 Carbocisteine

Dosage form

Syrup

The target audience

Adult

Expiration date in days

730

Dosage (volume) of the substance in the preparation

100 ml of syrup contains carbocisteine ​​5 g

Package weight, g

150

Information on technical characteristics, delivery set, country of manufacture